when will glp 1 become generic FDA Approves GLP-1 For Diabetes Launching GLP1 generic for T2DM

If needle-free delivery is essential, PlexusDx's oral semaglutide ($249/mo) offers FDA-backed pharmacokinetics, though still less effective than injection

Animal toxicology studies conducted during drug development found no direct evidence of harm to nursing offspring, though human lactation studies remain limited

Systematic meta-analyses have established that sulfonylurea therapy shows no protective effect against prostate cancer development in patients with diabetes mellitus [102]

Treatment persistence has improved compared to earlier GLP-1 formulations, though discontinuation rates remain significant, often due to gastrointestinal side effects or cost concerns

A limitation of these studies is the absence of stratification of heart failure patients based on ejection fraction, therefore additional clinical research specifically investigating the effects of GLP-1 receptor agonists in patients with heart failure with preserved ejection fraction (HFpEF) is warranted [94]

[DOI] [PMC free article] [PubMed] [Google Scholar] 95.Lin CL, et al